Additionally, Trop2 is cleaved via a protease, disintegrin and metalloproteinase 17 (ADAM17), resulting in the release of the Trop2 extracellular domain into the extracellular environment18, making it a potential liquid marker of prostate cancer. Here, TACSTD2 is linked to prostate cancer.